Ethic Inc. lifted its position in shares of Constellium SE (NYSE:CSTM - Free Report) by 114.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 77,794 shares of the industrial products company's stock after acquiring an additional 41,527 shares during the period. Ethic Inc. owned approximately 0.05% of Constellium worth $799,000 as of its most recent filing with the Securities & Exchange Commission.
Other hedge funds also recently added to or reduced their stakes in the company. Deutsche Bank AG lifted its stake in Constellium by 33.9% during the 4th quarter. Deutsche Bank AG now owns 125,389 shares of the industrial products company's stock valued at $1,288,000 after acquiring an additional 31,713 shares during the period. D. E. Shaw & Co. Inc. boosted its holdings in Constellium by 112.2% in the fourth quarter. D. E. Shaw & Co. Inc. now owns 2,426,033 shares of the industrial products company's stock worth $24,915,000 after purchasing an additional 1,282,587 shares during the last quarter. Cresset Asset Management LLC boosted its holdings in Constellium by 203.0% in the fourth quarter. Cresset Asset Management LLC now owns 62,800 shares of the industrial products company's stock worth $645,000 after purchasing an additional 42,071 shares during the last quarter. Bridgeway Capital Management LLC bought a new stake in Constellium in the 4th quarter worth approximately $8,615,000. Finally, Capstone Investment Advisors LLC purchased a new stake in Constellium during the 4th quarter valued at $7,138,000. 92.59% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
Separately, Deutsche Bank Aktiengesellschaft upgraded Constellium from a "hold" rating to a "buy" rating and set a $15.00 price target on the stock in a research note on Tuesday, February 25th.
Check Out Our Latest Report on CSTM
Constellium Stock Performance
Shares of CSTM traded up $0.24 on Tuesday, reaching $12.40. The company's stock had a trading volume of 150,980 shares, compared to its average volume of 1,432,213. The stock's 50 day simple moving average is $10.18 and its two-hundred day simple moving average is $10.63. The company has a debt-to-equity ratio of 1.93, a current ratio of 1.28 and a quick ratio of 0.52. The stock has a market capitalization of $1.77 billion, a P/E ratio of 38.84 and a beta of 1.65. Constellium SE has a 12-month low of $7.33 and a 12-month high of $22.00.
Constellium (NYSE:CSTM - Get Free Report) last released its quarterly earnings results on Wednesday, April 30th. The industrial products company reported $0.26 earnings per share for the quarter, topping the consensus estimate of $0.07 by $0.19. Constellium had a net margin of 0.67% and a return on equity of 4.83%. The business had revenue of $1.98 billion for the quarter, compared to the consensus estimate of $1.88 billion. During the same period last year, the firm earned $0.11 earnings per share. The company's quarterly revenue was up 5.3% on a year-over-year basis. Research analysts forecast that Constellium SE will post 1.1 earnings per share for the current fiscal year.
About Constellium
(
Free Report)
Constellium SE, together with its subsidiaries, engages in the design, manufacture, and sale of rolled and extruded aluminum products for the packaging, aerospace, automotive, defense, and other transportation and industry end-markets. The company operates through three segments: Packaging & Automotive Rolled Products, Aerospace & Transportation, and Automotive Structures & Industry.
Read More

Before you consider Constellium, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Constellium wasn't on the list.
While Constellium currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.